| Unique ID issued by UMIN | UMIN000009118 |
|---|---|
| Receipt number | R000004292 |
| Scientific Title | A randomised trial comparing gemcitabine vs TS-1 in patients with resected pancreatic cancer. |
| Date of disclosure of the study information | 2012/10/15 |
| Last modified on | 2014/04/15 09:44:55 |
A randomised trial comparing gemcitabine vs TS-1 in patients with resected pancreatic cancer.
A randomised trial comparing gemcitabine vs TS-1
A randomised trial comparing gemcitabine vs TS-1 in patients with resected pancreatic cancer.
A randomised trial comparing gemcitabine vs TS-1
| Japan | Asia(except Japan) |
resected pancreas cancer
| Hepato-biliary-pancreatic surgery |
Malignancy
YES
A randomised phase comparing gemcitabine vs TS-1 in patients with resected pancreatic cancer:Adjuvant Therapy for Pancreatic Cancer.
Efficacy
Confirmatory
Pragmatic
Phase III
time to recurrence
over all survival
safty
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
| Medicine |
GEM
TS-1
| 65 | years-old | <= |
| 65 | years-old | > |
Male and Female
patients never had malignacy before pancreas cancer.
age
allegy
Patietns aggremant
60
| 1st name | |
| Middle name | |
| Last name | Keiichi kubota |
Dokkyo Medical University
Second Department of Surgery
880 Kitakobayashi, Mibu, Tochigi, Japan
0282-87-2158
shimodamitsugi@hotmail.com
| 1st name | |
| Middle name | |
| Last name | Mitsugi Shimoda |
Dokkyo Medical University
Second Department of Surgery
880 Kitakobayashi, Mibu, Tochigi, Japan
0283-87-2158
shimodamitsugi@hotmail.com
Dokkyo Medical University
Dokkyo Medical University
Self funding
NO
| 2012 | Year | 10 | Month | 15 | Day |
Partially published
Completed
| 2008 | Year | 01 | Month | 01 | Day |
| 2008 | Year | 01 | Month | 10 | Day |
| 2012 | Year | 10 | Month | 15 | Day |
| 2014 | Year | 04 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004292